Christopher R. Watts, Ph.D. is Dean and Professor in the Harris College of Nursing & Health Sciences at Texas Christian University. His clinical, teaching, and research interests center on voice and swallowing impairments.

Eline WAUTERS studied Biochemistry and Biotechnology at the University of Antwerp, Belgium. After obtaining her MSc degree, she joined the group of Prof. Dr. Christine Van Broeckhoven (Antwerp, Belgium). There, she performed her PhD on the topic of genetic modifiers of onset age of frontotemporal dementia. After finalizing her PhD in 2017, her postdoctoral work now focuses on progranulin-related frontotemporal lobar degeneration and the identification of onset age modifiers.

Sandrina Weber graduated from the medical school of the Technical University of Munich. After one year of neurogenomics research, she began her neurology residency and research into biomarkers of parkinson’s disease at the Paracelsus-Elena-Klinik in Kassel, one of the largest specialized movement disorder clinics in Europe. Continuing both residency and research, she is currently a resident at the Department of Neurology, University Medical Center Goettingen.

Erica M. Weekman, PhD is a research track Assistant Professor at the Sanders-Brown Center on Aging. Dr. Weekman’s research focuses on both Alzheimer’s disease and vascular contributions to cognitive impairment and dementia (VCID). VCID is the second most common cause of dementia behind only Alzheimer’s disease. Interestingly, Alzheimer’s disease patients commonly have VCID as a co-morbidity. She is focusing on the molecular mechanisms of homocysteine-induced VCID and when it is co-morbid with Alzheimer’s disease pathologies.

Director of Integrative rehabilitation department, National Research Centre for Rehabilitation Technical Aids; General secretary and executive director of Alzheimer's Disease & Cognitive Rehabilitation Committee, China Association Rehabilitation Medicine; Principal investigator of a National Key Research and Development Program of China; Leader of a National CME project; Leading talent of Beijing E-town.

Bodil Weidung was born in Uppsala, Sweden which is where she currently holds a postdoctoral position at Uppsala University studying the link between herpes simplex virus and Alzheimer's Disease. She received her master and PhD degrees in Medicine at Umeå University in Umeå, Sweden and her medical licence at Uppsala University Hospital in Uppsala, Sweden. She has also studied medicine internationally at Harvard University, USA, Augustana College, USA, Université Henri-Poincaré, France and Universitas Gadjah Mada, Indonesia.

Dr. Weiner has been conducting research for more than 50 years and is Principal Investigator of the Alzheimer's Disease Neuroimaging Initiative (ADNI), and the BrainHealthRegistry.org, an internet-based registry with the overall goal of accelerating development of effective treatments for brain diseases. Dr. Weiner’s research largely focuses on treatment to slow progression in Alzheimer’s disease, and on early detection and prevention. Dr. Weiner completed his M.D in 1965, his internship and residency in 1967, and a residency and clinical fellowship in at Yale-New Haven Medical Center in 1968. He was an Assistant Professors at Stanford in 1974, and Associate Professor at UCSF in 1980 when he was one of the first to perform MRS on an intact animal. He subsequently pursued development of MRI/MRS as a clinical tool. Since 1990, he’s been a Professor in Radiology, Medicine, Psychiatry and Neurology at UCSF. Dr. Weiner has published 923 peer-reviewed articles, holds 19 separate research grants, and has received numerous honors. He was awarded the Outstanding Young Investigator of the American College of Cardiology in1976, the VA Middleton Award ,the Gold Medal of Paul Sabatier University and the City of Toulouse, the Ronald and Nancy Reagan Award for Research from the Alzheimer’s Association; in 2013, the Potamkin Prize, in 2014 the Distinguished Investigator Award from Academy of Radiology Research; in 2021, the Henry Wisniewski Lifetime Achievement Award in Alzheimer's Disease Research, from the Alzheimer's Association.

Me and my group members focuses on identifying new early mechanisms and biomarkers associated with Alzheimer's disease (AD) and thereby improve the development of new treatments and diagnostic tools. Our strategy is to investigate the effect of AD risk factors like stress, inflammation, metabolic changes, and amyloidogenesis, on different types of brain cells including pericytes, astrocytes, neurons, and NG2 cells. We use a translational approach where our hypotheses are built upon postmortem brain observations. These are followed up by in vitro experiments and studies on human CSF and plasma, and approach which has helped us to reveal several new mechanisms and biomarkers associated with AD, including alteration of glycogen metabolism, the toxicity of various amyloid peptides aggregation forms, and secretion of a variety of pathology-specific molecules. We hope that the gained knowledge will help us to distinguish and understand different pathways that fuel AD progression in humans and thereby push the development of individual tailor-made therapeutic interventions forward.

Dr. Milton Werner is the President and Chief Executive Officer of Inhibikase Therapeutics, a company developing novel protein kinase inhibitor therapeutics to treat neurodegenerative disease and viral infection inside and outside of the brain. Previously, Dr. Werner served as Vice President of Research at Celtaxsys, a cell-free immunotherapeutics company. From September 1996 until June 2007, Dr. Werner was a Head of the Laboratory of Molecular Biophysics at The Rockefeller University in New York City. Throughout his scientific career, Dr. Werner has been an innovator integrating chemistry, physics, and biology into a comprehensive approach to solving problems in medicine, including an explanation of the origin of “maleness” in humans, the mechanistic basis of several forms of leukemia and lymphoma and, more recently, the development of therapeutics that can halt and potentially reverse functional loss in neurodegenerative disease. Dr. Werner is the author or co-author of more than 70 research articles, reviews, and book chapters and has given lectures on his research work throughout the world. He is the recipient of numerous private and public research grants totaling more than $30 million. He is the recipient of several awards, including the Naito Memorial Foundation Prize, the Young Investigator Award from the Sidney Kimmel Cancer Foundation, the Research Chair from the Brain Tumor Society, and a $1 million Distinguished Young Scholars in Medical Research Award from the W. M. Keck Foundation. Dr. Werner received his Doctor of Philosophy in Chemistry from the University of California, Berkeley, and his Bachelor of Science in Biochemistry from the University of Southern California, and he was an NIH intramural postdoctoral fellow prior to his tenure at the Rockefeller University.

Sophia Wheatley is a PhD student in the Westman neuroimaging lab at Karolinska Institutet in Sweden. Her background is in psychology and previously studied at the University of Glasgow. Currently she is researching into the heterogeneity within Alzheimer's disease using various imaging techniques such as FDG-PET and structural MRI.

Tim is a PhD student in the Division of Psychiatry, University College London, UK. His work focuses on people with subjective cognitive decline (SCD). Tim seeks to identify those individuals with SCD who are most likely to experience a worsening of their symptoms, as well as non-drug strategies to help stop or slow down the process of decline.

Consultant Senior Lecturer in Movement Disorders Neurology at the University of Bristol & Honorary Consultant Neurologist at North Bristol Trust, UK. Alan Whone leads a regional movement disorders clinical service at the Bristol Brain Centre that conducts approximately 4000 people with Parkinson’s reviews per year from the diagnostic to the palliative stage. This service includes one of the largest deep brain stimulation surgery programmes for movement disorders in the UK, performing over 60 new implantations per annum. Alan’s PhD research employed Positron Emission Tomography to assess rates of progression in people with early Parkinson’s randomised to L-dopa or the dopamine agonist Ropinirole (Ann Neurol. 2003). The REAL-PET study is in the canon of controversial trials in Parkinson’s but nevertheless sparked Alan’s interest in disease modification in Parkinson’s disease. From late 2011 to early 2017 he was chief investigator of two single-centre academic-led studies assessing the efficacy of Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Parkinson’s. These investigations employed a novel mechanism of administration, involving a skull-mounted port, to achieve intraputaminal convection-enhanced delivery (CED) of study-drug on a monthly basis. The studies reported in Brain and the Journal of Parkinson’s in 2019 disease raise important questions on where next for neurorestorative therapies in Parkinson’s.

Donna M. Wilcock, PhD, is the Robert P. and Mildred A. Moores Endowed Chair in Alzheimer’s Disease at the Sanders-Brown Center on Aging and Professor in the Department of Physiology at the University of Kentucky. She also serves as Assistant Dean of Biomedicine in the College of Medicine. Dr. Wilcock was received her Bachelor’s degree in Pharmacology from Cardiff University. She obtained her Ph.D. at the University of South Florida, and completed postdoctoral training at Albert Einstein College of Medicine and Duke University. Her research is focused on vascular cognitive impairment and dementia (VCID), a common cause of dementia and frequent co-morbidity with Alzheimer’s disease pathology. She is performing translational research on VCID, ranging from studying molecular mechanisms through identification of novel biomarkers in patients. She is primarily focused on inflammatory and angiogenic processes, as well as studying the influence VCID has on the progression and severity of Alzheimer's disease. In addition, Donna serves as the Biomarker Core Director for the University of Kentucky Alzheimer’s Disease Research Center. Her work is funded by the National Institute on Aging and the National Institute on Neurological Disorders and Stroke.

DR. WILLIAMS SHEKINAH YOBUH A diligent, hardworking and focused medical doctor. A graduate of the University of Ibadan College of Medicine, the highest ranked medical school in Nigeria. Address: No.65 Kano street, off Kwandere road, Lafia, Nasarawa state Phone: 08065951155 Email: shekinahwilli29@gmail.com OBJECTIVE • A clinically competent doctor possessing adequate knowledge and research skills relevant for solving local and global health problems. EDUCATION • Wesley Methodist and Primary School 1999 - 2005 • Solid Rock International College 2005 - 2010 • Cambridge A level, Trioses Cambridge Academy 2013 - 2014 (Distinction in Biology) • University of Ibadan, Bachelor of Medicine; Bachelor of Surgery (MB;BS), 2015 - 2021 EXPERIENCE • Student Research Network (STURN), University of Ibadan, Founding member 2016 - Present Content Development Officer 2018 - 2019 President 2019 - 2021 Trained over 40 students for 30 hours annually on the basics of research • College Research and Innovation Hub, College of Medicine, University of Ibadan Founding member Assistant Content Development Officer 2019 - 2021 Trained over 40 students on research and innovation basics annually • Medical Assistant - St. Stephen Church Community Health Outreach, Ibadan 2018 Provided health information and services to over 40 villagers in Ibadan, Nigeria • Medical Assistant at Deeper Life Campground Health Post, Ibadan 2019 Examined and treated over 100 people at a religious organization • Medical Assistant at Mobolaji Hospital, Ibadan 2021 Examined and treated over 10 patients PUBLICATIONS Peer-reviewed publications • Olubunmi E. Odyemi, Chiamaka B. Offorbuike, Oluwasegun Eniayekan, Eniola Olusanya, Shekinah Williams, Salau H. Moromoke, Oluwadamilola A. Adeniyi, Suliyat Olawuwo, Abiodun Akintayo, Samuel Olawale, Chinweoge Epum, Jesujuwon Olawuyi, Philip Alabi, Lordstrong Akano. Patterns of Associated Injuries in Patients with Mild/Moderate Head Injuries. European Journal of Medical and Educational Technologies. 2021 • S. Williams, S. Adeyemi, J. Eyitayo, E. Odeyemi, E. Dada, M. Adesina, A. Akintayo. Mobile Health Technology in Combating COVID-19: Uses, Challenges and Recommendation. European Journal of Medical and Educational Technologies. 2020 Submitted manuscript • Olubunmi E. Odeyemi, Oloruntoba Ogunfolaji, James Eyitayo, Shekinah Williams, Michael Akande & Onaopemipo Akinola. Knowledge, Attitude and Practices Towards Preventive Strategies Against Covid-19 Pandemic Among Nigerian Young Adults: A Cross-Sectional Survey. International Journal of Medical sstudents. 2020 Non-Peer Reviewed Publications: • S. Williams (2020).What you need to know about sleep and brain functioning. Available at: https://www.easternherald.com/blog/what-you-need-to-know-about-sleep-and-brain-functioning-62849/ • S. Williams (2020). Doctor say coronavirus may cause strokes in young patients with no known risk for stroke. Available at: https://www.google.com/amp/s/www.easternherald.com/health/coronavirus-causes-stroke-in-young-adults-63637/ SCIENTIFIC PRESENTATIONS • S. Williams, S. Adeyemi, M. Aremu, C. Uzuegbunam, E. Dada, E. Iyawe, P. Olapade, Z. Quadri, D. Jokanola, J. Obasi, M. Adesina, B. Shofu. Effectiveness of high quality mobile phone applications in preventing COVID-19. Youth, Technology and Health Conference, 2020 • Olubunmi E. Odeyemi, Oloruntoba Ogunfolaji, James Eyitayo, Shekinah Williams, Michael Akande & Onaopemipo Akinola. Knowledge, Attitude and Practices Towards Preventive Strategies Against Covid-19 Pandemic Among Nigerian Young Adults: A Cross-Sectional Survey. FAMSA West Africa Regional Meeting. 2020 • Olubunmi E. Odyemi, Chiamaka B. Offorbuike, Oluwasegun Eniayekan, Eniola Olusanya, Shekinah Williams, Salau H. Moromoke, Oluwadamilola A. Adeniyi, Suliyat Olawuwo, Abiodun Akintayo, Samuel Olawale, Chinweoge Epum, Jesujuwon Olawuyi, Philip Alabi, Lordstrong Akano. Patterns of Associated Injuries in Patients with Mild/Moderate Head Injuries. European Journal of Medical and Educational Technologies, 2021 CONFERENCES AND WORKSHOPS Local conferences, Nigeria • Federation of African Medical Students General Assembly (FAMSA GA), 2018 International conferences • International Aids Conference (AIDS 2020), 2020 • International Conference on ICT Enhanced Social Sciences and Humanities (ICTeSSH), 2020 • Youth, Tech and Health Conference (YTH Live) 2020 • Edinburgh University Neurological Society International Conference (EUNSIC) 2021 • Innervate International Neurology and Neurosurgery Conference 2021 • 19th ASEAN NS/Inaugural AAN Step into the Future 2021 • WFNS Neurosurgical Anatomy 12th Live Webinar COURSES • Basic Trauma Life Support, 2017 University College Hospital, Ibadan • Nigerian National Code for Health Research and Ethics, 2019 West African Bioethics Training Program • Public Health Research, 2019 West African Bioethics Training Program AWARDS AND ACHIEVEMENTS • Best Male Upcoming Scientist in Nigeria, MONSTRATEC, Abuja, 2011 • Medicos Inter Medical school quiz competition Ile-Ife (3rd position), 2019 • Inter Medical school quiz competition (1st position), 2019 Nigerian Medical Student Association • Certificate of Recognition, 2020 The Eastern Herald Magazine, India SKILLS • Academic Writing • Google Digital Skills and Microsoft Office Suite (Word, Excel, Powerpoint) • Data collection and analysis REFEREES • Rufus Akinyemi, +2348033704384, rufusakinyemi@yahoo.com Consultant Neurologist, University College Hospital, Ibadan • Augustine Adeolu, +2348032477341, adeoluaa@yahoo.com Consultant Neurosurgeon and Professor, University College Hospital, Ibadan • Okechukwu Ogah, +2348067747121, osogah56156@gmail.com Consultant Cardiologist, University College Hospital, Ibadan • Adewale Badru, +2348033596328, badruwale@yahoo.com Consultant Anesthesiologist, University College Hospital, Ibadan